Arch Venture Management, Llc

会社	共有, %
Lyell Immunopharma, Inc.	12.99
Vir Biotechnology, Inc.	9.26
Rapport Therapeutics, Inc.	7.82
EQRx, Inc.	7.45
Unity Biotechnology, Inc.	5.99
Singular Genomics Systems, Inc.	5.13
Beam Therapeutics Inc.	4.46
Erasca, Inc.	3.57
Gossamer Bio	3.48
Q32 Bio Inc	2.6
CERo Therapeutics Holdings, Inc.	0.08